Since PD-L1 level in cancer cells is considered to be a major predictive marker of PD-1/PD-L1 antibody response (Sanmamed and Chen, 2018), it is of primary importance to analyze the expression and subcellular distribution of PD-L1 in glioma tissues. This evidence concerns the gene CD274 and cancer.